Amulya Sreekumar
@amulyasreekumar.bsky.social
650 followers 510 following 23 posts
Research Associate - Chodosh Lab (Dept. of Cancer Biology, University of Pennsylvania) Cancer Biology | Dormancy | Developmental Biology | Glycobiology
Posts Media Videos Starter Packs
amulyasreekumar.bsky.social
Comprehensive experiments in pre-clinical models and clinical data analysis demonstrate that dormancy creates a unique window of opportunity to deplete minimal residual disease and delay recurrence. Congratulations to all the authors on this important body of work!
Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial - Nature Medicine
A combination of mouse model data and data from a randomized phase 2 trial in patients with breast cancer in remission demonstrates feasibility, safety and a reduction in residual tumor cells followin...
www.nature.com
Reposted by Amulya Sreekumar
natnano.nature.com
New paper online:

Ångström-resolution imaging of cell-surface glycans.

The molecular organization of sugars in the native #glycocalyx has been resolved at 9 ångström using bioorthogonal metabolic labeling and #superresolution imaging of DNA barcodes.

#Glycotime

www.nature.com/articles/s41...
Ångström-resolution imaging of cell-surface glycans - Nature Nanotechnology
By combining bioorthogonal metabolic labelling and resolution enhancement through sequential imaging of DNA barcodes, the molecular organization of individual sugars in the native glycocalyx has been ...
www.nature.com
Reposted by Amulya Sreekumar
vikasnavaratna.bsky.social
World central kitchen has been doing great work consistently. Every meal counts. Donate here.

donate.wck.org/give/525879/...
amulyasreekumar.bsky.social
As a budding scientist, the idea that form follows function led me to a career studying developmental biology and how these principles are distorted in cancer. Excited to share this preprint reporting a surprising transdifferentiation of breast cancer cells unlocked by dormancy. Link below:
biorxiv-cancer.bsky.social
Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy https://www.biorxiv.org/content/10.1101/2025.05.07.652632v1
Reposted by Amulya Sreekumar
dev-journal.bsky.social
Apply for our Pathway to Independence programme, a scheme supporting postdocs going on the job market in 2025 with training, mentorship, profile-raising and networking opportunities. Apply by 31 Jan 2025: https://buff.ly/3VJGgDC
Pathway to independence: a new initiative supporting postdocs on the job market
Reposted by Amulya Sreekumar
meera-sundaram.bsky.social
#aECM (apical extracellular matrix) is a subset of #ECMatrix that is distinct from stromal matrices or basement membranes. Anybody out there studying #mucins #ZPproteins #cuticle #glycocalyx #surfactant or the like? We need to find each other and start talking!
Reposted by Amulya Sreekumar
jcstark.bsky.social
The secret is out! 🚀 Thrilled to support Valora's mission to bring our #AbLec technology to patients, alongside co-inventor @carolynbertozzi.bsky.social. More to come, and in the meantime, you can learn more about AbLecs here:
www.biorxiv.org/content/10.1...
Reposted by Amulya Sreekumar
obenaufa.bsky.social

Pls share 🌟Join the IMP as a Group Leader
We are 👀 for a colleague, ready to lead a groundbreaking research program. Enjoy generous funding, outstanding facilities & a vibrant scientific community in one of the world's most livable cities @impvienna.bsky.social
👉https://tinyurl.com/impgl2025
amulyasreekumar.bsky.social
Done! Nice seeing you here Lance
amulyasreekumar.bsky.social
Of course! You're on the list
amulyasreekumar.bsky.social
Thanks, Manuel! You're in the pack.
Reposted by Amulya Sreekumar
drglycoben.bsky.social
#SFG24 was so much fun - amazing #glycotime in a fantastic place. The right mix between talks by legends in the field and early career colleagues. Thank you to the organizers!
I contributed our own story on xylosyltransferase bump-and-hole engineering, check here: www.biorxiv.org/content/10.1...